KENNEY CHRISTOPHER JOHN
Chief Medical Officer
KENNEY CHRISTOPHER JOHN has filed 3 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Sep 1, 2026.
On the most recent filing, KENNEY CHRISTOPHER JOHN is listed as Chief Medical Officer at Xenon Pharmaceuticals Inc. Inside the rolling window, KENNEY CHRISTOPHER JOHN reported no open-market purchases and 3 open-market sales totaling $670K in XENE. The largest disclosed transaction in the window is a sale of 7,068 XENE shares on Aug 28, 2026, worth $426K.
Companies traded
Other insiders at XENE
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$670K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has KENNEY CHRISTOPHER JOHN made?
KENNEY CHRISTOPHER JOHN has filed 3 SEC Form 4 filings (6 transaction rows) across 1 company since 2026.
Which companies does KENNEY CHRISTOPHER JOHN trade?
KENNEY CHRISTOPHER JOHN has filed SEC Form 4 disclosures for 1 company, including XENE.
When was KENNEY CHRISTOPHER JOHN's most recent SEC Form 4 filing?
KENNEY CHRISTOPHER JOHN's most recent SEC Form 4 filing on Tracefour is dated Sep 1, 2026.
What is KENNEY CHRISTOPHER JOHN's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, KENNEY CHRISTOPHER JOHN is listed as Chief Medical Officer.
What is KENNEY CHRISTOPHER JOHN's total buy and sell value in the current window?
Inside the rolling retention window, KENNEY CHRISTOPHER JOHN bought $0 and sold $670K based on SEC Form 4 filings.
What was KENNEY CHRISTOPHER JOHN's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 7,068 XENE shares on 2026-08-28, worth $426K, per SEC Form 4 filings.